These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31144209)

  • 1. Complement System: a Neglected Pathway in Immunotherapy.
    Bordron A; Bagacean C; Tempescul A; Berthou C; Bettacchioli E; Hillion S; Renaudineau Y
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):155-171. PubMed ID: 31144209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.
    Meyer S; Leusen JH; Boross P
    MAbs; 2014; 6(5):1133-44. PubMed ID: 25517299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells.
    Tammen A; Derer S; Schwanbeck R; Rösner T; Kretschmer A; Beurskens FJ; Schuurman J; Parren PW; Valerius T
    J Immunol; 2017 Feb; 198(4):1585-1594. PubMed ID: 28062698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.
    Taylor RP; Lindorfer MA
    Semin Immunol; 2016 Jun; 28(3):309-16. PubMed ID: 27009480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic complement inhibition: new developments.
    Emlen W; Li W; Kirschfink M
    Semin Thromb Hemost; 2010 Sep; 36(6):660-8. PubMed ID: 20865643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis serum complement activity in infants during their first year of life].
    Grigorek Kh; Imel'ska D; Madalin'ski K; Sabboikh K; Van'ko LV; Sukhikh GT
    Akush Ginekol (Mosk); 1990 Jan; (1):38-40. PubMed ID: 2353731
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement in monoclonal antibody therapy of cancer.
    Rogers LM; Veeramani S; Weiner GJ
    Immunol Res; 2014 Aug; 59(1-3):203-10. PubMed ID: 24906530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin drugs do not affect serum complement activation in vitro.
    Lappegård KT; Hvassing T; Mollnes TE
    Scand J Immunol; 2004; 60(1-2):178-83. PubMed ID: 15238087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic Processes Induce Complement Activation via Classical Pathway in Porcine Neuroretinas.
    Mueller-Buehl AM; Buehner T; Pfarrer C; Deppe L; Peters L; Dick BH; Joachim SC
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.
    Harboe M; Ulvund G; Vien L; Fung M; Mollnes TE
    Clin Exp Immunol; 2004 Dec; 138(3):439-46. PubMed ID: 15544620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 12. A New Tool for Complement Research:
    Mutti M; Ramoni K; Nagy G; Nagy E; Szijártó V
    Front Immunol; 2018; 9():2770. PubMed ID: 30564230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern determination of complement activation.
    Oppermann M; Würzner R
    Semin Thromb Hemost; 2010 Sep; 36(6):611-9. PubMed ID: 20865637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in antibody-based tumor therapy.
    Derer S; Beurskens FJ; Rosner T; Peipp M; Valerius T
    Crit Rev Immunol; 2014; 34(3):199-214. PubMed ID: 24941073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of complement: the overture.
    Kinoshita T
    Immunol Today; 1991 Sep; 12(9):291-5. PubMed ID: 1755940
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement as a Biological Tool to Control Tumor Growth.
    Macor P; Capolla S; Tedesco F
    Front Immunol; 2018; 9():2203. PubMed ID: 30319647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated complement activation in pathology and protection.
    Goldberg BS; Ackerman ME
    Immunol Cell Biol; 2020 Apr; 98(4):305-317. PubMed ID: 32142167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.
    Cook EM; Lindorfer MA; van der Horst H; Oostindie S; Beurskens FJ; Schuurman J; Zent CS; Burack R; Parren PW; Taylor RP
    J Immunol; 2016 Sep; 197(5):1762-75. PubMed ID: 27474078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of complement in mAb-based therapies of cancer.
    Taylor RP; Lindorfer MA
    Methods; 2014 Jan; 65(1):18-27. PubMed ID: 23886909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.